Robin Guo
Chief Executive Officer Lionbio
Seminars
Thursday 4th February 2027
Improving Bioavailability Through Smarter Formulation Design: Enhancing Performance Without Increasing Development Complexity
12:00 pm
- Explore how nanoparticle-enabled delivery systems can overcome absorption barriers associated with peptides and biologics while minimizing systemic exposure
- Understand how intranasal GLP-1 delivery may create differentiated therapeutic profiles by targeting CNS pathways while potentially reducing gastrointestinal side effects
- Learn how developers are balancing bioavailability, manufacturability, safety, and scalability when advancing next-generation peptide therapies
